• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医源性感染与社区获得性感染:科学和社会面临的新挑战。

Healthcare-associated versus community-acquired infections: a new challenge for science and society.

机构信息

Institute of Hygiene and Environmental Medicine, Charité University Medicine Berlin, National Reference Centre for Surveillance of Nosocomial Infections, Hindenburgdamm 27, D-12203 Berlin, Germany.

出版信息

Int J Med Microbiol. 2010 Aug;300(6):342-5. doi: 10.1016/j.ijmm.2010.04.007. Epub 2010 May 7.

DOI:10.1016/j.ijmm.2010.04.007
PMID:20452277
Abstract

Healthcare and community associated MRSA are meanwhile exchanged in all directions between hospitals, long-term care facilities, nursing homes, and the community. This article is focusing on the situation concerning MRSA, but the situation concerning other multidrug-resistant (MDR) pathogens such as vancomycin-resistant enterococci or MDR Gram-negative pathogens is similar. Some European countries have started national campaigns to improve the situation significantly. They require the successful cooperation between healthcare facilities, public health authorities, health insurances, quality management and patient safety organizations, educational facilities, the public, and the veterinarian sector. These activities in the society need scientific data to provide evidence for the intervention measures and support their implementation. To really support the activities in the society, intervention studies are urgently needed to provide a more robust basis for decisions to improve the situation.

摘要

与此同时,医疗机构、长期护理机构、养老院和社区之间也在相互传播医疗保健相关和社区获得性耐甲氧西林金黄色葡萄球菌(MRSA)。本文主要关注 MRSA 的情况,但万古霉素耐药肠球菌或多药耐药革兰氏阴性病原体等其他多药耐药(MDR)病原体的情况也类似。一些欧洲国家已经开始开展国家运动,以显著改善这种情况。这些运动需要医疗机构、公共卫生当局、健康保险、质量管理和患者安全组织、教育机构、公众和兽医部门之间的成功合作。这些社会活动需要科学数据来为干预措施提供证据,并支持其实施。为了真正支持社会活动,迫切需要开展干预研究,为改善这种情况的决策提供更有力的依据。

相似文献

1
Healthcare-associated versus community-acquired infections: a new challenge for science and society.医源性感染与社区获得性感染:科学和社会面临的新挑战。
Int J Med Microbiol. 2010 Aug;300(6):342-5. doi: 10.1016/j.ijmm.2010.04.007. Epub 2010 May 7.
2
Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.耐多药葡萄球菌和肠球菌的流行病学及耐药问题。
Clin Microbiol Infect. 2009 Mar;15(3):224-31. doi: 10.1111/j.1469-0691.2009.02739.x.
3
Multiresistant Gram-negative infections: a global perspective.多重耐药革兰氏阴性菌感染:全球视角。
Curr Opin Infect Dis. 2010 Dec;23(6):546-53. doi: 10.1097/QCO.0b013e32833f0d3e.
4
Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.关于使用主动监测培养法筛查耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的立法授权:美国医疗保健流行病学学会(SHEA)与美国感染控制与流行病学专业人员协会(APIC)联合特别工作组的立场声明
Am J Infect Control. 2007 Mar;35(2):73-85. doi: 10.1016/j.ajic.2007.01.001.
5
Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.未来十年的超级细菌;2010年金黄色葡萄球菌、肠球菌属和铜绿假单胞菌的多重耐药性及治疗前景
Curr Opin Microbiol. 2007 Oct;10(5):436-40. doi: 10.1016/j.mib.2007.07.004. Epub 2007 Aug 30.
6
Guidelines for the control of glycopeptide-resistant enterococci in hospitals.医院中耐糖肽肠球菌控制指南。
J Hosp Infect. 2006 Jan;62(1):6-21. doi: 10.1016/j.jhin.2005.02.016. Epub 2005 Nov 28.
7
Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network.耐多药革兰氏阴性菌定义与分离程序的差异:美国医疗保健流行病学学会研究网络的一项调查
Infect Control Hosp Epidemiol. 2014 Apr;35(4):362-6. doi: 10.1086/675600.
8
Antimicrobial resistance in gram-positive bacteria.革兰氏阳性菌中的抗菌药物耐药性。
Am J Med. 2006 Jun;119(6 Suppl 1):S11-9; discussion S62-70. doi: 10.1016/j.amjmed.2006.03.012.
9
Methicillin-resistant Staphylococcus aureus: source control and surveillance organization.耐甲氧西林金黄色葡萄球菌:源头控制和监测组织。
Clin Microbiol Infect. 2009 Dec;15 Suppl 7:31-8. doi: 10.1111/j.1469-0691.2009.03096.x.
10
[Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].[血流感染分离细菌的耐药性监测:法国国家细菌对抗生素耐药性流行病学观察站(ONERBA)1998 - 2003年数据]
Med Mal Infect. 2005 Jun;35(6):329-34. doi: 10.1016/j.medmal.2005.05.002.

引用本文的文献

1
[Viruses and bacteria as infectious agents].[作为感染因子的病毒和细菌]
Urologie. 2024 Jul;63(7):709-712. doi: 10.1007/s00120-024-02319-1. Epub 2024 Apr 3.
2
Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview.预防医疗相关感染的策略:叙述性概述
Risk Manag Healthc Policy. 2020 Sep 28;13:1765-1780. doi: 10.2147/RMHP.S269315. eCollection 2020.
3
Probabilistic model for the estimation of the consumer exposure to methicillin-resistant Staphylococcus aureus due to cross-contamination and recontamination.
耐甲氧西林金黄色葡萄球菌经交叉污染和再污染导致的消费者暴露估计的概率模型。
Microbiologyopen. 2019 Nov;8(11):e900. doi: 10.1002/mbo3.900. Epub 2019 Jul 10.
4
What are the threats from antimicrobial resistance for maternity units in low- and middle- income countries?低收入和中等收入国家的产科病房面临哪些抗微生物药物耐药性带来的威胁?
Glob Health Action. 2016 Sep 16;9:33381. doi: 10.3402/gha.v9.33381. eCollection 2016.
5
A review of infection control in community healthcare: new challenges but old foes.社区医疗保健中的感染控制综述:新挑战与老问题
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2121-30. doi: 10.1007/s10096-014-2191-y. Epub 2014 Jul 4.
6
When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.严重脓毒症和感染性休克时如何以及何时覆盖耐药革兰氏阴性杆菌。
Curr Infect Dis Rep. 2011 Oct;13(5):416-25. doi: 10.1007/s11908-011-0200-1.
7
Binding of the gene repressor BlaI to the bla operon in methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌中基因抑制剂 BlaI 与 bla 操纵子的结合。
Biochemistry. 2010 Sep 21;49(37):7975-7. doi: 10.1021/bi101177a.